Skip to content
← Back to this collection

PUBLICATIONS · 21562038

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2011 Jul 14
First author
Matloub Y

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Matloub Y
      type
      Author
    2. name
      Bostrom BC
      type
      Author
    3. name
      Hunger SP
      type
      Author
    4. name
      Stork LC
      type
      Author
    5. name
      Angiolillo A
      type
      Author
    6. name
      Sather H
      type
      Author
    7. name
      La M
      type
      Author
    8. name
      Gastier-Foster JM
      type
      Author
    9. name
      Heerema NA
      type
      Author
    10. name
      Sailer S
      type
      Author
    11. name
      Buckley PJ
      type
      Author
    12. name
      Thomson B
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Matloub Y
      type
      Author
    2. name
      Bostrom BC
      type
      Author
    3. name
      Hunger SP
      type
      Author
    4. name
      Stork LC
      type
      Author
    5. name
      Angiolillo A
      type
      Author
    6. name
      Sather H
      type
      Author
    7. name
      La M
      type
      Author
    8. name
      Gastier-Foster JM
      type
      Author
    9. name
      Heerema NA
      type
      Author
    10. name
      Sailer S
      type
      Author
    11. name
      Buckley PJ
      type
      Author
    12. name
      Thomson B
      type
      Author
    bibliography ids
    1. nci-bib-b4d6f6cf512b3bebc3484b2a
    book metadata
    content sha256
    056f92fc9769b44b40cd4b43798ae97c67261e067b400035fd89fd7fc5f62ec1
    document type
    citation
    dois
    1. 10.1182/blood-2010-12-322909
    electronic publication date
    display
    2011 May 11
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21562038
    immutable id
    pubmed:21562038@056f92fc9769b44b40cd4b43798ae97c67261e067b400035fd89fd7fc5f62ec1
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    2
    name
    Blood
    nlm unique id
    7603509
    pages
    243-51
    volume
    118
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21562038
      provenance
      batch id
      a366a1bc8ed89d8d7ca5
      provider
      NCBI PubMed ESummary
      record sha256
      cf79abf8c82a4c9847ecac7dae20180c083eac106b592cf5a40435eb79b052bd
      response sha256
      c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
      retrieved at
      2026-09-09T23:46:40.540025+00:00
      publication date
      display
      2011 Jul 14
      precision
      day
      year
      2011
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Randomized Controlled Trial
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21562038/
      title
      Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice